PCM
APYX icon

Perkins Capital Management’s Apyx Medical APYX Stock Holding History

Perkins Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$155K Sell
42,000
-43,000
-51% -$161K 0.15% 77
2025
Q4 		$298K Buy
85,000
+4,000
+5% +$13.9K 0.24% 73
2025
Q3 		$173K Sell
81,000
-146,000
-64% -$309K 0.15% 75
2025
Q2 		$511K Buy
227,000
+21,500
+10% +$30.3K 0.51% 48
2025
Q1 		$282K Sell
205,500
-2,000
-1% -$2.76K 0.3% 67
2024
Q4 		$328K Sell
207,500
-10,000
-5% -$14K 0.29% 65
2024
Q3 		$270K Sell
217,500
-17,000
-7% -$21.5K 0.25% 69
2024
Q2 		$314K Buy
234,500
+6,000
+3% +$8.85K 0.3% 66
2024
Q1 		$311K Buy
228,500
+15,000
+7% +$31.9K 0.26% 71
2023
Q4 		$559K Buy
213,500
+1,700
+0.8% +$4.12K 0.48% 60
2023
Q3 		$678K Sell
211,800
-4,200
-2% -$19.6K 0.67% 45
2023
Q2 		$1.09M Sell
216,000
-8,800
-4% -$44.6K 0.95% 37
2023
Q1 		$647K Buy
224,800
+189,000
+528% +$552K 0.61% 50
2022
Q4 		$84K Buy
35,800
+14,800
+70% +$45.2K 0.09% 85
2022
Q3 		$94K Sell
21,000
-600
-3% -$4.3K 0.11% 88
2022
Q2 		$127K Buy
21,600
+11,300
+110% +$58K 0.13% 88
2022
Q1 		$67K Buy
+10,300
New +$101K 0.05% 104
2020
Q1 		$151K Sell
42,200
-300
-0.7% -$2.01K 0.18% 77
2019
Q4 		$360K Sell
42,500
-157,040
-79% -$1.13M 0.32% 74
2019
Q3 		$1.35M Sell
199,540
-54,500
-21% -$387K 1.16% 32
2019
Q2 		$1.71M Buy
254,040
+8,500
+3% +$46.2K 1.2% 28
2019
Q1 		$1.55M Sell
245,540
-220,160
-47% -$1.7M 1.02% 29
2018
Q4 		$3.02M Buy
465,700
+350
+0.1% +$2.12K 2.34% 6
2018
Q3 		$3.3M Buy
465,350
+64,650
+16% +$359K 1.98% 8
2018
Q2 		$1.74M Buy
400,700
+146,450
+58% +$540K 1.25% 22
2018
Q1 		$755K Sell
254,250
-212,050
-45% -$546K 0.68% 50
2017
Q4 		$1.21M Sell
466,300
-157,385
-25% -$491K 1.17% 27
2017
Q3 		$2.11M Buy
623,685
+23,868
+4% +$61.6K 2.21% 9
2017
Q2 		$1.48M Sell
599,817
-30,501
-5% -$75K 1.64% 16
2017
Q1 		$1.68M Sell
630,318
-1,717
-0.3% -$5.7K 1.74% 14
2016
Q4 		$2.27M Sell
632,035
-15,000
-2% -$66.8K 2.49% 8
2016
Q3 		$3.37M Buy
647,035
+291,295
+82% +$945K 3.37% 4
2016
Q2 		$583K Sell
355,740
-20,969
-6% -$36.4K 0.67% 52
2016
Q1 		$629K Buy
376,709
+2,000
+0.5% +$4.03K 0.79% 45
2015
Q4 		$787K Buy
374,709
+80,750
+27% +$156K 0.84% 39
2015
Q3 		$573K Hold
293,959
– – 0.64% 54
2015
Q2 		$820K Buy
293,959
+43,959
+18% +$121K 0.72% 46
2015
Q1 		$598K Buy
+250,000
New +$831K 0.5% 71

Other funds holding APYX

NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $9.23B AUM 27.52% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return